Mrc Technology

LONDON, January 17, 2011 - MRC Technology announced today that Mike Johnson has been appointed Director, Corporate Partnerships.

LONDON, July 12, 2010 - MRC Technology (UK) announced today that it has entered into an agreement with Genentech, Inc., a wholly owned member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) for an exclusive licence to a series of small molecule drug candidates for the potential treatment of neurological disease.